General
Synonym/Acronym:
Amiodarone (Cordarone); Digoxin (Digitek, Lanoxicaps, Lanoxin); disopyramide (Norpace, Norpace CR); flecainide (flecainide acetate, Tambocor); lidocaine (Xylocaine); procainamide (Procanbid, Pronestyl, Pronestyl SR); quinidine (Quinidex Extentabs, quinidine sulface SR, quinidine gluconate SR).
Common Use:
To evaluate specific drugs for subtherapeutic, therapeutic, or toxic levels in treatment of heart failure and cardiac arrhythmias.
Specimen:
Serum (1 mL) collected in a red-top tube.
| Drug | Route of Administration | Recommended Collection Time |
|---|
| Amiodarone | Oral | Trough: immediately before next dose |
| Digoxin | Oral | Trough: 12–24 hr after dose |
| | Never draw peak samples |
| Disopyramide | Oral | Trough: immediately before next dose |
| | Peak: 2–5 hr after dose |
| Flecainide | Oral | Trough: immediately before next dose |
| | Peak: 3 hr after dose |
| Lidocaine | IV | 15 min, 1 hr, then every 24 hr |
| Procainamide | IV | 15 min; 2, 6, 12 hr; then every 24 hr |
| Procainamide | Oral | Trough: immediately before next dose |
| | Peak: 75 min after dose |
| Quinidine sulfate | Oral | Trough: immediately before next dose |
| | Peak: 1 hr after dose |
| Quinidine gluconate | Oral | Trough: immediately before next dose |
| | Peak: 5 hr after dose |
| Quinidine polygalacturonate | Oral | Trough: immediately before next dose |
| | Peak: 2 hr after dose |
Normal Findings:
(Method: Immunoassay)
| Drug (Indication) | Therapeutic Range* | SI Units | Half-Life (hr) | Volume of Distribution (L/kg) | Protein Binding (%) | Excretion |
|---|
| (SI = Conventional Units × 1.60) |
| Amiodarone | 1.0–2.5 mcg/mL | 1.6–4.0 micromol/L | 250–1200 | 20–100 | 95–97 | 1° hepatic |
| (SI = Conventional Units × 1.28) |
| Digoxin | 0.5–2.0 ng/mL | 0.6–2.6 nmol/L | 20–60 | 7 | 20–30 | 1° renal |
| (SI = Conventional Units × 2.95) |
| Disopyramide (atrial arrhythmias) | 2.8–3.2 mcg/mL | 8.3–9.4 micromol/L | 4–10 | 0.7–0.9 | 20–60 | 1° renal |
| Disopyramide (ventricular arrhythmias) | 3.3–5.0 mcg/mL | 9.7–14.8 micromol/L | | | | 1° renal |
| (SI = Conventional Units × 2.41) |
| Flecainide | 0.2–1.0 mcg/mL | 0.5–2.4 micromol/L | 7–19 | 5–13 | 40–50 | 1° renal |
| (SI = Conventional Units × 4.27) |
| Lidocaine | 1.5–5.0 mcg/mL | 6.4–21.4 micromol/L | 1.5–2 | 1–1.5 | 60–80 | 1° hepatic |
| (SI = Conventional Units × 4.23) |
| Procainamide | 4–10 mcg/mL | 17–42 micromol/L | 2–6 | 2–4 | 10–20 | 1° renal |
| N-acetyl procainamide | 10–20 mcg/mL | 42–85 micromol/L | 8 | | | 1° renal |
| (SI = Conventional Units × 3.08) |
| Quinidine | 2–5 mcg/mL | 6–15 micromol/L | 6–8 | 2–3 | 70–90 | Renal and hepatic |
| *Conventional units. |
Antiarrhythmic Drugs: Amiodarone Digoxin, Disopyramide, Flecainide, Lidocaine, Procainamide, Quinidine has been found in Davis's Lab & Diagnostic Tests
If you are a registered user, please login below.
If not, learn more about gaining full access.
- Login
- Try and Buy
- Nursing Central puts five fully integrated references at your fingertips on mobile devices and the web. See how Nursing Central works by clicking the sample entries below or purchase a subscription for the web and your mobile device.
View these free topics online now.